Abstract
Identification of myogenic cell targeting ligands is a critical step in the development of synthetic vectors for gene delivery to skeletal muscle. Here we describe the screening of six potential targeting ligands (insulin, insulin-like growth factor I, iron transferrin, gallium transferrin, alpha-bungarotoxin and carnitine) for their ability to bind dystrophin-deficient myotubes in vitro. Those ligands showing high levels of binding to myotubes were then tested on fully differentiated, isolated, viable myofibers. Of the ligands tested, transferrin showed the most promise based on high levels of binding to myogenic cells, high levels of receptor observed in regenerating fibers of patients with Duchenne muscular dystrophy and the ability to direct a large enzyme conjugate to the cytoplasm of myotubes. Finally, we show that incorporation of transferrin into an artificial virus consisting of poly- L-lysine-condensed DNA coated with a lipid shell (LPDII formulation) results in ligand-directed delivery of DNA to myogenic cells. This is the first report of gene transfer to myogenic cells using a ligand-directed synthetic vector. These results suggest that rational design of ligand-directed, fully synthetic, gene delivery vehicles is a viable approach to skeletal muscle vector development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Feero, W., Li, S., Rosenblatt, J. et al. Selection and use of ligands for receptor-mediated gene delivery to myogenic cells. Gene Ther 4, 664–674 (1997). https://doi.org/10.1038/sj.gt.3300453
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300453
Keywords
This article is cited by
-
Frizzled related protein deficiency impairs muscle strength, gait and calpain 3 levels
Orphanet Journal of Rare Diseases (2020)
-
Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors
Gene Therapy (2003)
-
Medicinal chemistry of plasmid DNA with peptide nucleic acids: A new strategy for gene therapy
International Journal of Peptide Research and Therapeutics (2003)
-
IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death
Cell Death & Differentiation (2000)
-
Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheres
Gene Therapy (1999)